PANTHERx® Ranks 1st in Patient Satisfaction for the 4th Quarter of 2017

pantherx modern healthcare best places to workPANTHERx® Specialty Pharmacy, The Rare Disease SP®, has once again earned the #1 ranking in the quarterly Patient Satisfaction Survey from Zitter Health Insights for the fourth quarter of 2017.  This ranking is based on the nearly 30 Specialty Pharmacies that received a statistically relevant sample of survey responses. PANTHERx® also received the first annual Specialty Pharmacy Patient Choice Award™ non-PBM/payer category for patient satisfaction in 2016, yet scored the highest mean score regardless of category.  PANTHERx® Specialty Pharmacy’s continuing performance in the Patient Satisfaction Survey demonstrates an ongoing commitment to providing uncompromising quality in patient care.

The Zitter Health Insights survey assesses numerous aspects of patient satisfaction and analyzes responses from ~10,000 specialty pharmacy patients across all specialty pharmacies every year. Their primary metric is Net Promoter Score (NPS), which is compiled by asking patients on a scale of 0 to 10 how likely they would be to recommend their specialty pharmacy to a friend or family member. PANTHERx® received an NPS of 95, 50 points higher than the industry average and 7 points higher than the next-highest scoring specialty pharmacy. Additionally, none of the patients surveyed offered a negative or detractor rating for PANTHERx.

“PANTHERx® Specialty Pharmacy is once again honored that our efforts are realized in not just the scores of this prestigious survey, but in the impact to individual lives of the patients to whom we dedicate ourselves each and every day,” Dr. Gordon J. Vanscoy, Chairman & CEO.

PANTHERx® received perfect NPS™ scores from its patients with HIV, hypophosphatasia and primary periodic paralysis. Furthermore, nearly 80% of PANTHERx® patients surveyed indicated that they would be “very unhappy” if they were forced to switch to a different specialty pharmacy. PANTHERx® is proud to have earned these high marks from its patients, validating its authentic dedication to quality patient care.

PANTHERx® Featured in Specialty Pharmacy Continuum

PANTHERx® Specialty Pharmacy’s Fellowship program was featured in an article published by Specialty Pharmacy Continuum on April 11, 2018. The fellowship is designed to help address an emerging need in pharmacy – professionals with experience and specializations in both the business and clinical aspects of specialty pharmacy. During the fellowship, the fellows rotate through different departments learning about business and pharmacy operations; quality improvement and clinical education; pharmacy analytics and reporting; and business development, and also strategic partnerships and managed markets. By the completion of the term, fellows are expected to coordinate and complete a focused research project and submit a manuscript of the work to a peer-reviewed journal.

The Specialty Pharmacy Continuum (www.specialtypharmacycontinuum.com) covers news and information relevant to specialty pharmacists, home infusion practitioners, managed care organizations, and other key providers of specialty pharmacy.

PANTHERx® sees this fellowship as an opportunity to not only develop and nurture new talent for specialty pharmacies, but also as a means to build relationships with talented young pharmacy professionals. In the article, Doug Gebhard, PharmD, MBA, the PANTHERx® Specialty Pharmacy’s Vice President of Quality and Education discussed the benefit of this program to PANTHERx® – “The ultimate goal is to create a pipeline of talented individuals who we can develop internally and then recruit into a role within the organization.”

The article also discussed the experience of PANTHERx®’s first fellow, Matt Misorski, PharmD. You can read about his experience by visiting this link (subscription required).

You can learn more about the fellowship at this link or e-mail fellowship@pantherspecialty.com. Applications have already been closed for the upcoming fellowship term that starts in July, but applicants for future fellowships are already under consideration.